ACCN2 has been shown to promote tumor growth and metastasis in breast cancer (Gupta et al, 2016), and GRIN2D is an angiogenic tumor marker in colorectal cancer (Ferguson et al, 2016). This evidence concerns the gene GRIN2D and breast carcinoma.